Related references
Note: Only part of the references are listed.Sequential treatment with 5-aza-2-deoxycytidine and deacetylase inhibitors reactivates HIV-1
Sophie Bouchat et al.
EMBO MOLECULAR MEDICINE (2016)
Didehydro-Cortistatin A: a new player in HIV-therapy?
Guillaume Mousseau et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2016)
CNS-specific regulatory elements in brain-derived HIV-1 strains affect responses to latency-reversing agents with implications for cure strategies
L. R. Gray et al.
MOLECULAR PSYCHIATRY (2016)
HIV reservoirs: what, where and how to target them
Melissa J. Churchill et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Getting into the brain: Potential of nanotechnology in the management of NeuroAIDS
Madhavan Nair et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance
Pornpun Vivithanaporn et al.
AIDS (2016)
A Drug-Free Zone-Lymph Nodes as a Safe Haven for HIV
Anna Licht et al.
CELL HOST & MICROBE (2016)
CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF
Sam Nightingale et al.
CYTOKINE (2016)
Improving combination antiretroviral therapy by targeting HIV-1 gene transcription
Valentin Le Douce et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells
Lachlan R. Gray et al.
JOURNAL OF NEUROVIROLOGY (2016)
KAP1 Recruitment of the 7SK snRNP Complex to Promoters Enables Transcription Elongation by RNA Polymerase II
Ryan P. McNamara et al.
MOLECULAR CELL (2016)
Persistent HIV-1 replication maintains the tissue reservoir during therapy
Ramon Lorenzo-Redondo et al.
NATURE (2016)
HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment
Deanna Saylor et al.
NATURE REVIEWS NEUROLOGY (2016)
Reversal of Latency as Part of a Cure for HIV-1
Thomas Aagaard Rasmussen et al.
TRENDS IN MICROBIOLOGY (2016)
HIV-1 Eracication: Early Trials (and Tribulations)
Adam M. Spivak et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Immune activation in the central nervous system throughout the course of HIV infection
Serena S. Spudich
CURRENT OPINION IN HIV AND AIDS (2016)
Preclinical shock strategies to reactivate latent HIV-1: an update
Gilles Darcis et al.
CURRENT OPINION IN HIV AND AIDS (2016)
Natural Products as Anti-HIV Agents and Role in HIV-Associated Neurocognitive Disorders (HAND): A Brief Overview
Kesava Rao V. Kurapati et al.
FRONTIERS IN MICROBIOLOGY (2016)
Nano-ART and NeuroAIDS
Malay K. Das et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2016)
A better screening tool for HIV-associated neurocognitive disorders: is it what clinicians need?
Marie-J. Brouillette et al.
AIDS (2015)
Cerebrospinal fluid analysis in the HIV infection and compartmentalization of HIV in the central nervous system
Sergio Monteiro de Almeida
ARQUIVOS DE NEURO-PSIQUIATRIA (2015)
Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications
Suzi Hong et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
The HIV-1 transgenic rat model of neuroHIV
Michael Vigorito et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Improving bioavailability and biodistribution of anti-HIV chemotherapy
Giovanna Giacalone et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations
Gregory M. Laird et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
HIV eradication symposium: will the brain be left behind?
B. J. Brew et al.
JOURNAL OF NEUROVIROLOGY (2015)
Enigma of HIV-1 latent infection in astrocytes: an in-vitro study using protein kinase C agonist as a latency reversing agent
Ashok Chauhan
MICROBES AND INFECTION (2015)
HIV reservoirs as obstacles and opportunities for an HIV cure
Tae-Wook Chun et al.
NATURE IMMUNOLOGY (2015)
Cerebrospinal Fluid (CSF) CD8+T-Cells That Express Interferon-Gamma Contribute to HIV Associated Neurocognitive Disorders (HAND)
Rachel D. Schrier et al.
PLOS ONE (2015)
Characteristics and critical function of CD8+T cells in the Toxoplasma-infected brain
Tyler A. Landrith et al.
SEMINARS IN IMMUNOPATHOLOGY (2015)
Eradication of HIV-1 from the Macrophage Reservoir: An Uncertain Goal?
Wasim Abbas et al.
VIRUSES-BASEL (2015)
Effect of human immunodeficiency virus on blood-brain barrier integrity and function: an update
Venkata Subba Rao Atluri et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Changes in HIV reservoirs during long-term antiretroviral therapy
Feiyu F. Hong et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Bryostatin activates HIV-1 latent expression in human astrocytes through a PKC and NF-κB-dependent mechanism
Laura Diaz et al.
SCIENTIFIC REPORTS (2015)
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression
Gilles Darcis et al.
PLOS PATHOGENS (2015)
Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation
Guochun Jiang et al.
PLOS PATHOGENS (2015)
Epigenetic control of HIV-1 post integration latency: implications for therapy
Amit Kumar et al.
CLINICAL EPIGENETICS (2015)
Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy
Francesca Ferretti et al.
CURRENT HIV/AIDS REPORTS (2015)
Neuropathogenesis of HIV: From Initial Neuroinvasion to HIV-Associated Neurocognitive Disorder (HAND)
Zaina Zayyad et al.
CURRENT HIV/AIDS REPORTS (2015)
Challenges and opportunities for T-cell-mediated strategies to eliminate HIV reservoirs
Mark A. Brockman et al.
FRONTIERS IN IMMUNOLOGY (2015)
Can HIV-1-specific ADCC assist the clearance of reactivated latently infected cells?
Wen Shi Lee et al.
FRONTIERS IN IMMUNOLOGY (2015)
Activation of Latent Human Immunodeficiency Virus by the Histone Deacetylase Inhibitor Panobinostat: A Pilot Study to Assess Effects on the Central Nervous System
Thomas A. Rasmussen et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Dynamic Interaction Between Astrocytes and Infiltrating PBMCs in Context of NeuroAIDS
Maureen H. Richards et al.
GLIA (2015)
HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research
Melissa J. Churchill et al.
JOURNAL OF NEUROVIROLOGY (2015)
HIV-1 target cells in the CNS
Sarah B. Joseph et al.
JOURNAL OF NEUROVIROLOGY (2015)
Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation
Viktor Dahl et al.
AIDS (2014)
Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling
Guochun Jiang et al.
AIDS (2014)
Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice
Ariel Halper-Stromberg et al.
CELL (2014)
Monocytes Mediate HIV Neuropathogenesis: Mechanisms that Contribute to HIV Associated Neurocognitive Disorders
Dionna W. Williams et al.
CURRENT HIV RESEARCH (2014)
NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links
Ioannis Pateras et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Neuroprotective Activity of pDING in Response to HIV-1 Tat
Nune Darbinian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
The Many Lives of CTIP2: From AIDS to Cancer and Cardiac Hypertrophy
Valentin Le Douce et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
Targeting strategies for delivery of anti-HIV drugs
Lakshmi Narashimhan Ramana et al.
JOURNAL OF CONTROLLED RELEASE (2014)
An Example of Genetically Distinct HIV Type 1 Variants in Cerebrospinal Fluid and Plasma During Suppressive Therapy
Viktor Dahl et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
HIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategies
Paul R. Gorry et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases
M. C. Kowarik et al.
JOURNAL OF NEUROLOGY (2014)
Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIV infection and CART
J. Harezlak et al.
JOURNAL OF NEUROVIROLOGY (2014)
Epigenetic Regulation of HIV-1 Latency in Astrocytes
Srinivas D. Narasipura et al.
JOURNAL OF VIROLOGY (2014)
HMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters
Sebastian Eilebrecht et al.
NUCLEIC ACIDS RESEARCH (2014)
HIV-1 Entry and Trans-Infection of Astrocytes Involves CD81 Vesicles
Lachlan R. Gray et al.
PLOS ONE (2014)
Biomarker Evidence of Axonal Injury in Neuroasymptomatic HIV-1 Patients
Jan Jessen Krut et al.
PLOS ONE (2014)
Marine natural products: Bryostatins in preclinical and clinical studies
Peter Kollar et al.
PHARMACEUTICAL BIOLOGY (2014)
Triptolide inhibits human immunodeficiency virus type 1 replication by promoting proteasomal degradation of Tat protein
Zhitao Wan et al.
RETROVIROLOGY (2014)
Transcriptional control of HIV latency: Cellular signaling pathways, epigenetics, happenstance and the hope for a cure
Uri Mbonye et al.
VIROLOGY (2014)
The impact of microglial activation on blood-brain barrier in brain diseases
Anna Carolina Carvalho da Fonseca et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Is the central nervous system a reservoir of HIV-1?
Lachlan R. Gray et al.
CURRENT OPINION IN HIV AND AIDS (2014)
Anti-α4 Antibody Treatment Blocks Virus Traffic to the Brain and Gut Early, and Stabilizes CNS Injury Late in Infection
Jennifer H. Campbell et al.
PLOS PATHOGENS (2014)
Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND)
Vasudev R. Rao et al.
AIDS RESEARCH AND THERAPY (2014)
New hope for eradication of HIV from the body: the role of polymeric nanomedicines in HIV/AIDS pharmacotherapy
Jimma Likisa Lenjisa et al.
JOURNAL OF NANOBIOTECHNOLOGY (2014)
Cna Menges in HIV vaccine research for treatment and prevention
Barbara Ensoli et al.
FRONTIERS IN IMMUNOLOGY (2014)
Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers
Viktor Dahl et al.
AIDS (2013)
Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature
Amy R. Zipursky et al.
AIDS (2013)
Reduced Basal Transcriptional Activity of Central Nervous System-Derived HIV Type 1 Long Terminal Repeats
Lachlan R. Gray et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2013)
CD8 Encephalitis in HIV-Infected Patients Receiving cART: A Treatable Entity
Francois-Xavier Lescure et al.
CLINICAL INFECTIOUS DISEASES (2013)
CSF Penetration by Antiretroviral Drugs
Christine Eisfeld et al.
CNS DRUGS (2013)
Macrophages: the neglected barrier to eradication
Sarah A. Watters et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2013)
Monocyte/macrophages and their role in HIV neuropathogenesis
Tricia H. Burdo et al.
IMMUNOLOGICAL REVIEWS (2013)
Immunologic privilege in the central nervous system and the blood-brain barrier
Leslie L. Muldoon et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
Molecular and pathologic insights from latent HIV-1 infection in the human brain
Paula Desplats et al.
NEUROLOGY (2013)
Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects
Emily L. Ho et al.
PLOS ONE (2013)
CTIP2 is a negative regulator of P-TEFb
Thomas Cherrier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
HIV-1 transcription and latency: an update
Carine Van Lint et al.
RETROVIROLOGY (2013)
Pseudomonas DING proteins as human transcriptional regulators and HIV-1 antagonists
Andrew Suh et al.
VIROLOGY JOURNAL (2013)
Roles and functions of HIV-1 Tat protein in the CNS: an overview
Asen Bagashev et al.
VIROLOGY JOURNAL (2013)
Overcoming pharmacologic sanctuaries
Theodore J. Cory et al.
CURRENT OPINION IN HIV AND AIDS (2013)
Transcription Factors Mediate the Enzymatic Disassembly of Promoter-Bound 7SK snRNP to Locally Recruit P-TEFb for Transcription Elongation
Ryan P. McNamara et al.
CELL REPORTS (2013)
Comparison of HDAC inhibitors in clinical development Effect on HIV production in latently infected cells and T-cell activation
Thomas Aagaard Rasmussen et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load
Michael J. Peluso et al.
AIDS (2012)
Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients
Sophie Bouchat et al.
AIDS (2012)
Central nervous system: A modified immune surveillance circuit?
Tania Romo-Gonzalez et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
An Analog of the Natural Steroidal Alkaloid Cortistatin A Potently Suppresses Tat-Dependent HIV Transcription
Guillaume Mousseau et al.
CELL HOST & MICROBE (2012)
HIV-Associated Neurological Disorders A Guide to Pharmacotherapy
Ik L. Tan et al.
CNS DRUGS (2012)
Redefining the Viral Reservoirs that Prevent HIV-1 Eradication
Evelyn Eisele et al.
IMMUNITY (2012)
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
Liang Shan et al.
IMMUNITY (2012)
Cellular resistance to HIV-1 infection in target cells coincides with a rapid induction of X-DING-CD4 mRNA: Indication of the unique host innate response to virus regulated through function of the X-DING-CD4 gene
Rasheda Y. Shilpi et al.
INNATE IMMUNITY (2012)
Achieving a cure for HIV infection: do we have reasons to be optimistic?
Valentin Le Douce et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection
Victor Valcour et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
Camellia Banerjee et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Can Humanized Mice Reflect the Complex Pathobiology of HIV-Associated Neurocognitive Disorders?
Santhi Gorantla et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
NF-κB as a potential therapeutic target in microbial diseases
Mariateresa Vitiello et al.
MOLECULAR BIOSYSTEMS (2012)
NOTCH1 Nuclear Interactome Reveals Key Regulators of Its Transcriptional Activity and Oncogenic Function
Ahmad Yatim et al.
MOLECULAR CELL (2012)
LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing
Valentin Le Douce et al.
NUCLEIC ACIDS RESEARCH (2012)
Macrophages and their relevance in Human Immunodeficiency Virus Type I infection
Herwig Koppensteiner et al.
RETROVIROLOGY (2012)
The HIV-1 Env Protein: A Coat of Many Colors
Kathryn Twigg Arrildt et al.
CURRENT HIV/AIDS REPORTS (2012)
The anatomical and cellular basis of immune surveillance in the central nervous system
Richard M. Ransohoff et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Towards an HIV cure: a global scientific strategy
Steven G. Deeks
NATURE REVIEWS IMMUNOLOGY (2012)
Eradication of HIV from the brain: reasons for pause
Avindra Nath et al.
AIDS (2011)
Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment
Jarek Harezlak et al.
AIDS (2011)
Brain Cell Reservoirs of Latent Virus in Presymptomatic HIV-Infected Individuals
Katherine A. Thompson et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Screening for Cognitive Impairment in Human Immunodeficiency Virus
Victor Valcour et al.
CLINICAL INFECTIOUS DISEASES (2011)
Drug transporter expression in human macrophages
Amelie Moreau et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2011)
HIV-1 Tat Protein Promotes Neuronal Dysfunction through Disruption of MicroRNAs
J. Robert Chang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Possibility of HIV-1 Resistance Mutations in Cerebrospinal Fluid From Persons Receiving Suppressive Therapy
Stephen J. Seligman
JOURNAL OF INFECTIOUS DISEASES (2011)
Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy
Viktor Dahl et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy
Alex Sigal et al.
NATURE (2011)
Human-Phosphate-Binding-Protein inhibits HIV-1 gene transcription and replication
Thomas Cherrier et al.
VIROLOGY JOURNAL (2011)
Targeting viral reservoirs: ability of antiretroviral therapy to stop viral replication
Frank Maldarelli
CURRENT OPINION IN HIV AND AIDS (2011)
Activation of HIV Transcription by the Viral Tat Protein Requires a Demethylation Step Mediated by Lysine-specific Demethylase 1 (LSD1/KDM1)
Naoki Sakane et al.
PLOS PATHOGENS (2011)
Astrocytes: biology and pathology
Michael V. Sofroniew et al.
ACTA NEUROPATHOLOGICA (2010)
Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patients
Amit C. Achhra et al.
AIDS (2010)
Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy
Ana Canestri et al.
CLINICAL INFECTIOUS DISEASES (2010)
HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment
Arvid Eden et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Simian Immunodeficiency Virus-Infected Macaques Treated with Highly Active Antiretroviral Therapy Have Reduced Central Nervous System Viral Replication and Inflammation but Persistence of Viral DNA
M. Christine Zink et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+T lymphocytes
Laetitia Redel et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage
Valentin Le Douce et al.
RETROVIROLOGY (2010)
Detectable cerebrospinal fluid HIV RNA with assoidated neurological deficits, despite suppression of HIV replication in the plasma compartment
Lucy J. Garvey et al.
AIDS (2009)
Extensive Astrocyte Infection Is Prominent in Human Immunodeficiency Virus-Associated Dementia
Melissa J. Churchill et al.
ANNALS OF NEUROLOGY (2009)
The transport of anti-HIV drugs across blood-CNS interfaces: Summary of current knowledge and recommendations for further research
Lavanya Varatharajan et al.
ANTIVIRAL RESEARCH (2009)
Identification of X-DING-CD4, a new member of human DING protein family that is secreted by HIV-1 resistant CD4+ T cells and has anti-viral activity
Adam Lesner et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Drug-resistant human immunodefiency virus
M. J. Kozal
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Uncontrolled Viral Replication as a Risk Factor for Non-AIDS Severe Clinical Events in HIV-Infected Patients on Long-Term Antiretroviral Therapy: APROCO/COPILOTE (ANRS CO8) Cohort Study
Tristan Ferry et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
A perspective on antiviral resistance
Paul D. Griffiths
JOURNAL OF CLINICAL VIROLOGY (2009)
CNS Inflammation and Macrophage/Microglial Biology Associated with HIV-1 Infection
Anjana Yadav et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
Proximal events in Wnt signal transduction
Stephane Angers et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Role of Tat Protein in HIV Neuropathogenesis
Wenxue Li et al.
NEUROTOXICITY RESEARCH (2009)
p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1
T. Cherrier et al.
ONCOGENE (2009)
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs
Christopher M. Coleman et al.
RETROVIROLOGY (2009)
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity
Steven G. Deeks et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system
Scott Letendre et al.
ARCHIVES OF NEUROLOGY (2008)
Cellular Reservoirs of HIV-1 and their Role in Viral Persistence
Aikaterini Alexaki et al.
CURRENT HIV RESEARCH (2008)
The multi-tasking P-TEFb complex
Vanessa Bres et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Bone-marrow-derived microglia: myth or reality?
Denis Soulet et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy
Aylin Yilmaz et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection
Lin Shen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
HIV-1 Infection of Bone Marrow Hematopoietic Progenitor Cells and Their Role in Trafficking and Viral Dissemination
Aikaterini Alexaki et al.
PLOS PATHOGENS (2008)
Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy
Arvid Eden et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Updated research nosology for HIV-associated neurocognitive disorders
A. Antinori et al.
NEUROLOGY (2007)
Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion
Elaine R. Thomas et al.
VIROLOGY (2007)
Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing
Celine Marban et al.
EMBO JOURNAL (2007)
Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure
Serena Spudich et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Blood-brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Yuri Persidsky et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2006)
Residual human immunodeficiency virus type 1 viremia in some patients on Antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells
JR Bailey et al.
JOURNAL OF VIROLOGY (2006)
Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model
SA Barber et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Use of laser capture microdissection to detect integrated HIV-1 DNA in macrophages and astrocytes from autopsy brain tissues
Melissa J. Churchill et al.
JOURNAL OF NEUROVIROLOGY (2006)
Cortistatins A, B, C, and D, anti-angiogenic steroidal alkaloids, from the marine sponge Corticium simplex
S Aoki et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
p27SJ, a novel protein in St John's Wort, that suppresses expression of HIV-1 genome
N Darbinian-Sarkissian et al.
GENE THERAPY (2006)
Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response
CL Ong et al.
JOURNAL OF VIROLOGY (2005)
Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus
S Kramer-Hämmerle et al.
VIRUS RESEARCH (2005)
Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation
N Vázquez et al.
JOURNAL OF VIROLOGY (2005)
COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells
C Marban et al.
NUCLEIC ACIDS RESEARCH (2005)
Plant substances as anti-HIV agents selected according to their putative mechanism of action
P Cos et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Multidrug resistance protein (MRP) 4-and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia
S Dallas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection
S Crowe et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Astrocyte infection by HIV-1: Mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia
PR Gorry et al.
CURRENT HIV RESEARCH (2003)
Three or more routes for leukocyte migration into the central nervous system
RM Ransohoff et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Recruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cells
O Rohr et al.
JOURNAL OF VIROLOGY (2003)
Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments
DC Nickle et al.
JOURNAL OF VIROLOGY (2003)
Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline
BO Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months
M Di Mascio et al.
JOURNAL OF VIROLOGY (2003)
Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells
O Rohr et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis
LY Poluektova et al.
JOURNAL OF IMMUNOLOGY (2002)
Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy
LQ Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Functional interactions between C/EBP, Sp1, and COUP-TF regulate human immunodeficiency virus type 1 gene transcription in human brain cells
C Schwartz et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
